Maria New

Maria New is a highly accomplished scientist with extensive experience in drug discovery and development. Currently serving as Principal Scientist at Pear Bio since April 2023, Maria leads drug discovery programs, manages CRO activities, and utilizes advanced methodologies such as CRISPR and multiparametric imaging for drug target validation. Previously, Maria held principal scientist roles at Relation Therapeutics and GSK, where notable achievements included leading innovative drug discovery projects and receiving the IPTC award. Maria's background also includes significant research experience as a postdoctoral fellow at The Francis Crick Institute and Cancer Research UK, as well as consultancy at Oxford Cancer Biomarkers. Maria holds a Ph.D. in Oncology and an MBA, both from prestigious institutions, complemented by a Master’s Degree in Biochemistry.